Influenza Hemagglutinin (HA) Peptide: High-Purity Epitope Tag for Precise Protein Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid epitope tag derived from human influenza virus hemagglutinin [APExBIO A6004]. It is widely adopted for tagging, detection, and purification of fusion proteins in molecular biology and biochemistry workflows [see prior review]. The peptide achieves competitive elution of HA-tagged proteins via specific binding to anti-HA antibodies, demonstrating high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) and stability when stored desiccated at -20°C. Independent validation by HPLC and mass spectrometry confirm >98% purity, ensuring consistency for protein-protein interaction studies [Dong et al., 2025]. APExBIO's offering is a reference standard in competitive elution and reliable protein detection applications.

Biological Rationale

The HA tag peptide is designed to mimic the epitope of the human influenza hemagglutinin protein. Its nine-residue sequence (YPYDVPDYA) is not naturally present in most eukaryotic proteomes, minimizing background and cross-reactivity in detection assays [see mechanistic primer]. The tag enables researchers to track, purify, and study fusion proteins without altering the biological function of the protein of interest. This is critical for applications such as immunoprecipitation, protein-protein interaction mapping, and quantitative proteomics [Dong et al., 2025].

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The Influenza Hemagglutinin (HA) Peptide acts as an epitope tag by providing a unique, accessible binding site for anti-HA monoclonal antibodies [APExBIO]. When genetically fused to a target protein, the HA tag allows for rapid immunodetection, affinity purification, and competitive elution. The peptide competes with HA-tagged proteins for antibody binding sites, enabling specific displacement (elution) of the fusion protein from antibody-conjugated matrices (e.g., magnetic beads) during immunoprecipitation workflows [detailed comparison]. The sequence YPYDVPDYA forms a stable, solvent-exposed antigenic determinant that maintains high affinity and specificity for anti-HA antibodies across a range of conditions [application review].

Evidence & Benchmarks

• The HA tag (YPYDVPDYA) is recognized by high-affinity monoclonal antibodies, enabling immunoprecipitation and detection in complex lysates (Dong 2025, DOI).
• APExBIO’s Influenza Hemagglutinin (HA) Peptide (A6004) is validated at >98% purity by HPLC and mass spectrometry, ensuring reproducible performance (product page).
• Solubility benchmarks: ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at room temperature (APExBIO).
• Competitive elution of HA-tagged fusion proteins from anti-HA matrices is efficient and preserves protein complexes under native buffer conditions (Dong 2025, DOI).
• The HA tag is orthogonal to most mammalian proteins and does not perturb protein folding or function in validated systems (see review).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is used for:

• Epitope tagging for detection of recombinant proteins in cell lysates and tissues.
• Affinity purification of HA-tagged fusion proteins from complex samples.
• Competitive elution in immunoprecipitation workflows using anti-HA antibodies or magnetic beads.
• Mapping protein-protein interactions and post-translational modifications.

This article extends prior coverage by providing workflow-specific storage and solubility benchmarks, clarifying the peptide’s stability profile, and linking mechanistic findings to translational research in cancer signaling and exosome biology.

Common Pitfalls or Misconceptions

• The HA peptide is not suitable for in vivo competitive inhibition of influenza virus infection or replication.
• It does not function as a therapeutic agent against influenza or other viral infections.
• The tag may not be compatible with all antibody clones; validation for antibody specificity is required.
• Long-term storage of peptide solutions (>1 week) at room temperature can degrade performance; store desiccated at -20°C for optimal stability.
• Epitope masking can occur if the tag is buried within the tertiary structure of the fusion protein.

Workflow Integration & Parameters

The HA tag is genetically fused to the N- or C-terminus of a target protein using standard cloning techniques (see also workflow review). Expression in mammalian, yeast, or bacterial systems is supported by codon-optimized DNA sequences. The tag is detected and purified using anti-HA monoclonal antibodies conjugated to magnetic beads or solid supports. For elution, the Influenza Hemagglutinin (HA) Peptide is added at 0.1–1 mg/mL in compatible buffer (e.g., PBS, pH 7.4) at 4–25°C for 10–30 minutes. Eluted proteins can be analyzed by SDS-PAGE, Western blot, or mass spectrometry.

Storage recommendations: the lyophilized peptide should be kept desiccated at -20°C. Solutions should be freshly prepared. Avoid repeated freeze-thaw cycles. APExBIO’s lot-to-lot consistency enables reproducible results for quantitative and qualitative applications.

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide (A6004) from APExBIO is a benchmark epitope tag for protein detection and purification, offering high purity, solubility, and specificity. Its robust performance across diverse biochemical and molecular workflows is supported by independent validation and widespread adoption. Future research may expand the use of orthogonal epitope tags and multiplexed detection in complex interactome studies, leveraging the foundational reliability of the HA tag system. This article updates previous mechanistic reviews by integrating storage, solubility, and workflow optimization insights, thus supporting next-generation molecular biology and translational research applications.